AUPH News and Press, Aurinia Pharmaceuticals Inc From 08/06/21

Gainers: Kaixin (NASDAQ:KXIN) +50%. Sphere 3D (NASDAQ:ANY) +42%. Westport Fuel Systems (NASDAQ:WPRT) +25%. SCWorx (NASDAQ:WORX) +24%. Aurinia Pharmaceuticals (NASDAQ:AUPH) +22%. LiveRamp Holdings (NYSE:RAMP) +20%. Grid Dynamics (NASDAQ:GDYN) +19%. Bit Digital (NASDAQ:BTBT) +19%. Switch (NYSE:...

Gainers: SCWorx (NASDAQ:WORX) +28%, Aurinia Pharmaceuticals (NASDAQ:AUPH) +21%, BeyondSpring (NASDAQ:BYSI) +13%, Intersect ENT (NASDAQ:XENT) +12%, Caribou Biosciences (NASDAQ:CRBU) +11%. Losers: Dicerna Pharmaceuticals (NASDAQ:DRNA) -35%, iCAD (NAS...

Image source: The Motley Fool. Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Q2 2021 Earnings Call Aug 5, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcr...

Sphere 3D Corp (NASDAQ:ANY) +43% agreement to acquire exclusive rights for assignment of cryptocurrency mining assets Kaixin Auto (NASDAQ:KXIN) +23% on foraying into new energy vehicle business Switch (NYSE:SWCH) +19% on Q2 earnings Westport Fuel (NASDAQ:WPRT) +1...

Aurinia Pharmaceuticals (NASDAQ:AUPH) continues its yesterday's post-market rally and is up 14.7% premarket after it reported financial results for Q2 ended June 30, 2021. The company recorded robust revenue growth of 624% to $6.6M over prior quarter, ahead of analyst estimate of $5...

Aurinia Pharmaceuticals Inc. (AUPH) Q2 2021 Earnings Conference Call August 5, 2021 16:30 ET Company Participants Glenn Schulman - Senior Vice President of Corporate Communications & Investor Relations Peter Greenleaf - President & Chief Executive Officer Joe Miller - Chief Financial ...

Aurinia Pharma (NASDAQ:AUPH): Q2 GAAP EPS of -$0.37 misses by $0.01. Revenue of $6.62M (+21966.7% Y/Y) beats by $1.66M. Gross margin for the three and six months ended June 30, 2021 was ~95%. “As we continue to expand patient access to LUPKYNIS across the United States, we anticip...

– $6.6 million in net revenue for the second quarter 2021 (624% increase from first quarter 2021) – – 415 patient start forms (PSFs) received for LUPKYNIS™ during the second quarter (over a 60% increase from the first quarter 2021) and over 800 PSFs recei...

Earnings season continues for Motley Fool investors this week. There are still plenty of great Canadian stocks to buy before a quick boost from hopefully strong earnings. So, here are four I would consider watching as earnings come out August 5 and even buying ahead of time for a quick litt...

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that it will release its second quarter 2021 financial results on Thursday, August 5, 2021, after the markets close. Aurinia’s management team will also host a conference call at ...